# Improvement the Anti-migraine Treatment Efficacy by Tailoring the Drug to Individual's Pain Modulation Profile

> **NCT01470339** · NA · COMPLETED · sponsor: **Rambam Health Care Campus** · enrollment: 200 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** duloxetine

## Key facts

- **NCT ID:** NCT01470339
- **Lead sponsor:** Rambam Health Care Campus
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12
- **Primary completion:** 2014-07
- **Final completion:** 2014-07
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2015-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01470339

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01470339, "Improvement the Anti-migraine Treatment Efficacy by Tailoring the Drug to Individual's Pain Modulation Profile". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01470339. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*